Many companies are choosing to outsource the manufacture of their highly potent compounds for strategic and/or economic reasons.
This white paper outlines some of the elements that should be considered by a sponsor pharmaceutical company when outsourcing secondary processing (i.e. dosage form transfer, scale-up and commercial manufacture) of a highly potent product.
Outsourcing High Potency Product Manufacturing: Key Selection Criteria
Oct. 28, 2014